Quimi Daphne
- SEC CIK
- 0001543031
No open-market purchases or sales filed in the past year.
Current role at each company
- IPSC Century Therapeutics, Inc.Directoras of Jun 12, 2026
- AMLX Amylyx Pharmaceuticals, Inc.Directoras of Jun 8, 2026
- FOLD Amicus Therapeutics, Inc.Chief Financial Officeras of Jan 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Quimi Daphne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IPSC Century Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | Quimi DaphneDirector | PPurchase | +5.00K | $1.53 | +$7.65K | New position5.00K after |
AMLX Amylyx Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 (view filing) | May 14-15 | 2 days | Quimi DaphneDirector | PPurchase | +5.00K | $1.89 | +$9.45K | New position5.00K after | 2 lots |
FOLD Amicus Therapeutics, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 (view filing) | Jan 17-18 | 2 days | Quimi DaphneChief Financial Officer | SSale | −11.9K | $12.79 | −$152.4K | −2.9%398.5K after | 2 lots |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Quimi DaphneChief Financial Officer | SSale | −4.40K | $11.29 | −$49.6K | −1.3%335.3K after | |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Quimi DaphneChief Financial Officer | SSale | −5.80K | $12.00 | −$69.6K | −1.7%339.7K after | |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Quimi DaphneChief Financial Officer | SSale | −4.40K | $9.00 | −$39.6K | −1.3%345.5K after |